đźšš Free Worldwide Shipping on All Orders!Shop Now
HomeStore

Cancer Test for Female (CANFE)

Product image 1

Cancer Test for Female (CANFE)

About the Cancer Test for Female (CANFE)

Direct answer: The CANFE profile is a blood test package that measures tumour marker levels to support early cancer risk screening in women.

The Cancer Test for Female (CANFE) is a preventive screening profile that evaluates specific tumour markers — proteins or hormones released by certain cancers — to help identify potential cancer-related changes at an early stage. This profile includes the following tests:

Tests Covered in CANFE Profile

  1. Beta Human Chorionic Gonadotropin Hormone (BHCG)
  2. Alpha Feto Protein (AFP)
  3. CA 125
  4. CA 15.3
  5. CA 19.9
  6. Carcino Embryonic Antigen (CEA)

These markers assist doctors in assessing risks related to ovarian, breast, gastrointestinal and reproductive system cancers. In Pune, Maharashtra, India, healthcare nt sickcare offers this profile with Home Collection Facility and Direct Walk-in Facility for convenient testing.

This test is commonly advised when there is unexplained weight loss. It supports evaluation of suspected cancer conditions before further medical investigation.

Sample & Reporting

A blood sample is analysed to measure tumour marker concentrations.

Patient References

Prepare correctly using our test preparation guides, learn about women’s health screening in our health tips articles, compare preventive packages at compare health checkups, or review diagnostic services at our services.

Explore All Diagnostic Tests

Browse the complete catalogue on our All Tests hub page from healthcare nt sickcare.

Frequently Asked Questions

It measures tumour markers to support early detection and monitoring of cancer risks in women.
It is advised for preventive screening or when there is family history or symptoms suggesting cancer risk.
Fasting is generally recommended for accurate tumour marker measurement.
No. It indicates risk levels, but diagnosis requires clinical correlation and imaging.

 

Disclaimer: This content is for informational purposes only and does not replace medical consultation. Always seek professional medical advice. Read our disclaimer policy.

Images on this page are AI-generated using Google Gemini and Shopify Magic. Shopify Magic

$899.70

Original: $2,999.00

-70%
Cancer Test for Female (CANFE)—

$2,999.00

$899.70

Product Information

Shipping & Returns

Description

About the Cancer Test for Female (CANFE)

Direct answer: The CANFE profile is a blood test package that measures tumour marker levels to support early cancer risk screening in women.

The Cancer Test for Female (CANFE) is a preventive screening profile that evaluates specific tumour markers — proteins or hormones released by certain cancers — to help identify potential cancer-related changes at an early stage. This profile includes the following tests:

Tests Covered in CANFE Profile

  1. Beta Human Chorionic Gonadotropin Hormone (BHCG)
  2. Alpha Feto Protein (AFP)
  3. CA 125
  4. CA 15.3
  5. CA 19.9
  6. Carcino Embryonic Antigen (CEA)

These markers assist doctors in assessing risks related to ovarian, breast, gastrointestinal and reproductive system cancers. In Pune, Maharashtra, India, healthcare nt sickcare offers this profile with Home Collection Facility and Direct Walk-in Facility for convenient testing.

This test is commonly advised when there is unexplained weight loss. It supports evaluation of suspected cancer conditions before further medical investigation.

Sample & Reporting

A blood sample is analysed to measure tumour marker concentrations.

Patient References

Prepare correctly using our test preparation guides, learn about women’s health screening in our health tips articles, compare preventive packages at compare health checkups, or review diagnostic services at our services.

Explore All Diagnostic Tests

Browse the complete catalogue on our All Tests hub page from healthcare nt sickcare.

Frequently Asked Questions

It measures tumour markers to support early detection and monitoring of cancer risks in women.
It is advised for preventive screening or when there is family history or symptoms suggesting cancer risk.
Fasting is generally recommended for accurate tumour marker measurement.
No. It indicates risk levels, but diagnosis requires clinical correlation and imaging.

 

Disclaimer: This content is for informational purposes only and does not replace medical consultation. Always seek professional medical advice. Read our disclaimer policy.

Images on this page are AI-generated using Google Gemini and Shopify Magic. Shopify Magic